Ajuste direto para aquisição de T1140 - TRIPTORRELINA (PÓ P/ SOL INJ) [0.1 MG/ML; 1 ML; FRS] e T202 - TRIPTORRELINA (PÓ P/ SUSP INJ) [3,75MG; FRS/ SERINGA] para suprir necessidades na área da saúde.

ID 12478475 · Portal BASE
Price
Base Price
€18,450 .00
Effective Price
€1,538 .00 -91.7%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.
NIF 502609800
Company
Dates
Publication
09 Jan 2026
Celebration
08 Jan 2026
Contracting Entity
Centro Hospitalar Universitário de Lisboa Norte, EPE
NIF 508481287
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
18450.0
Total effective price
1538.0
Ratio
0.0834
Direction
reduction
Rule
A9 price reduction: ratio 0.0834 outside [0.5, 1.5]
Detected 2026-03-06